专题：Neurofibromatosis and Schwannoma Cases

This cluster of papers focuses on Neurofibromatosis Type 1 and Type 2, genetic disorders characterized by the development of tumors in the nervous system. The research covers various aspects including the role of tumor suppressor genes, Schwann cell origin of neurofibromas, cognitive deficits associated with the condition, and the molecular mechanisms underlying the disease.
最新文献
近5年高被引文献
Overview of the 2022 WHO Classification of Paragangliomas and Pheochromocytomas

article Full Text OpenAlex 429 FWCI71.3071

Advancing therapy for neuroblastoma

review Full Text OpenAlex 415 FWCI13.4201

Dabrafenib plus Trametinib in Pediatric Glioma with BRAF V600 Mutations

article Full Text OpenAlex 299 FWCI42.2918

Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: An international consensus recommendation

article Full Text OpenAlex 296 FWCI26.1259

Meningioma DNA methylation groups identify biological drivers and therapeutic vulnerabilities

article Full Text OpenAlex 294 FWCI36.6259

Nirogacestat, a γ-Secretase Inhibitor for Desmoid Tumors

article Full Text OpenAlex 276 FWCI47.3967

European Neuroendocrine Tumour Society ( ENETS ) 2023 guidance paper for nonfunctioning pancreatic neuroendocrine tumours

article Full Text OpenAlex 259 FWCI43.0927

Efficacy and Safety of Trametinib Monotherapy or in Combination With Dabrafenib in Pediatric BRAF V600–Mutant Low-Grade Glioma

article Full Text OpenAlex 189 FWCI17.3704

The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial

article Full Text OpenAlex 188 FWCI26.6319

Recent advances in the developmental origin of neuroblastoma: an overview

article Full Text OpenAlex 183 FWCI16.7342